IL-6-Th17/IL-17 activation is linked to osteoclastogenesis in chronic gouty arthritis
Introduction The mechanisms of chronic gouty arthritis (CGA) and its progressive bone destruction remain poorly understood. The purpose of this study was to explore the potential involvement of interleukin (IL)-6 and T helper 17 (Th17)/IL-17 responses in CGA-associated osteoclast formation. Methods Fifty-nine patients with gout and 28 healthy controls (HCs) were enrolled in this study. Transcriptome sequencing, Enzyme-Linked Immunosorbent Assay (ELISA) and flow cytometry were used to detect the levels of cytokines and Th17 cells’ response in CGA patients. Th17-enriched T-cell co-culture and IL-6/IL-17 neutralization experiments were used to assess the osteoclast formation in vitro . The effect of triptolide (TP) was evaluated in PBMC cultures, and the clinical changes following treatment with tripterygium glycoside (TG) were retrospectively examined in four CGA patients. Results CGA patients showed enrichment of IL-17 signaling, and the levels of CXCL1, CXCL2, IL-6 and IL-23 were cooperatively elevated. Also, the Th17-cell frequency, IL-17 production, and the capacity of naive T cells to differentiate into Th17 cells were also increased in CGA patients, which could be suppressed by anti-IL-6 antibody. Furthermore, CGA-derived Th17-enriched T cells increased osteoclast formation in co-culture, whereas IL-6 and IL-17 neutralization reduced osteoclast formation. And TP treatment in vitro showed lower IL-6 levels and reduced osteoclast formation in CGA. The four-patient treated with TG showed exploratory changes in inflammatory biomarkers and peripheral Th17 frequency after treatment. Discussion The findings support the potential involvement of IL-6/Th17/IL-17 responses in osteoclast formation in CGA, which links immune disorder to osteoclast activation, and provide a potential strategy for the use of Tripterygium-derived agents in CGA treatment.
Authors
- Na Xu (ORCID: https://orcid.org/0000-0001-6414-9494)
- Hong Di
- Yun Zhang
- Xuejun Zeng
- Bingqing Zhang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-13
- DOI
- https://doi.org/10.3389/fimmu.2026.1996564
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China